Synapse - Oxford University Press

Oxford University Press

SHERPA: Yellow

People

Drilon
Motzer
Mellinghoff
Shuman
Rosenblum
Dunkel
Karajannis
Saltz
Souweidane
Panageas

Groups

Department of Medicine (1995)
Solid Tumor Oncology Division (1624)
GSK Faculty (765)
Survivorship Research (639)
Population Sciences Research Program (615)
Epidemiology and Biostatistics (465)
Department of Pathology and Laboratory Medicine (415)
Gastrointestinal Oncology Service (386)
Genitourinary Oncology Service (367)
Tow Center for Developmental Oncology (TCDO) (352)

Search Within

Results (4676)

Export to EndNote / Excel

Debio1347, an oral FGFR inhibitor: Results from a single center study in pediatric patients with recurrent/refractory FGFR altered gliomas

Meeting Abstract

Sait, S. F.; Rosenblum, M.; Bale, T.; Haque, S.; Gilheeney, S.; Spatz, K.; Prince, D.; Ibanez, K.; Dunkel, I.; Karajannis, M.
Neuro-Oncology (2020)

Fulltext@MSK | Save

Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed (ND) or recurrent/refractory (R/R) glioblastoma (GBM); Phase 1B/2 study update

Meeting Abstract

Piotrowski, A.; Puduvalli, V.; Wen, P.; Colman, H.; Campian, J.; Pearlman, M.; Butowski, N.; Cloughesy, T.; Battiste, J.; Glass, J.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

Phase II study of everolimus (Afinitor®) for children with recurrent or progressive ependymoma

Meeting Abstract

Bowers, D.; Karajannis, M.; Gardner, S.; Su, J.; Baxter, P.; Partap, S.; Klesse, L.
Neuro-Oncology (2020)

Fulltext@MSK | Save

Pilot study of repeated planned glucarpidase following high dose methotrexate (HD-MTX) in CNS lymphoma (CNSL)

Meeting Abstract

Schaff, L.; Lobbous, M.; Sener, U.; Gavrilovic, I.; Miller, A.; Stone, J.; Piotrowski, A.; Skakodub, A.; Madzsar, J.; Schumpp, A.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

Preliminary results of the abemaciclib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): A phase II platform trial using Bayesian adaptive randomization

Meeting Abstract

Wen, P.; Trippa, L.; Lee, E.; Fell, G.; Rahman, R.; Arrillaga-Romany, I.; Touat, M.; McCluskey, C.; Brunno, J.; Gaffey, S.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

Activity of larotrectinib in tropomyosin receptor kinase (TRK) fusion cancer patients with central nervous system (CNS) metastases

Meeting Abstract

Patel, J. D.; Farago, A. F.; Hong, D. S.; Lassen, U. N.; Leyvraz, S.; Park, K.; Sohal, D. P. S.; Solomon, B.; Reeves, J. A.; Dima, L.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

Maintenance chemotherapy using bevacizumab for neurofibromatosis 2 patients with hearing loss and progressive vestibular schwannomas: An NF Clinical Trials Consortium Study (NF104)

Meeting Abstract

Plotkin, S.; Tonsgard, J.; Ullrich, N.; Allen, J.; Blakeley, J.; Dhall, G.; Campian, J.; Clapp, W.; Fisher, M.; Cutter, G.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

CC-115 in newly diagnosed MGMT unmethylated glioblastoma in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): A phase II randomized Bayesian adaptive platform trial

Meeting Abstract

Rahman, R.; Trippa, L.; Fell, G.; Lee, E.; Arrillaga-Romany, I.; Touat, M.; McCluskey, C.; Brunno, J.; Gaffey, S.; Drappatz, J.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

Diffusion MR imaging derived apparent diffusion coefficient as a potential biomarker of clinical outcome in recurrent central nervous system lymphoma